<DOC>
	<DOCNO>NCT00822562</DOCNO>
	<brief_summary>In study , intend divide subject confirm recurrent HCC two group : Group A : treatment pure surgery Group B : treatment pure radio frequency . We compare non-tumor survival time , long-term survival rate two group , summarize merit demerit group , try establish standardized therapy treatment kind patient prospective study molecular biological difference pathological sample first second surgery .</brief_summary>
	<brief_title>Research Surgery Micro-Invasive Treatment Recurrent Primary Liver Cancer</brief_title>
	<detailed_description>The recurrence metastasis primary liver cancer ( PLC ) always tough problem surgeon . Gu Hong-guang report five year recurrence rate PLC subject reach 75~100 % , among 60 % discover within three year surgery , peak appear 18~24 month . According report deliver Zhong-Shan Hospital , recurrence rate small HCC 40 % , large HCC 1.9 time small HCC . Chen Han agree recurrence rate 1~2 year reach 71.6 % , 2~11 year 28.4 % . With rapid development iconography surgical technique , possible surgeon resect recurrent HCC . In 1986 , Nagasue et al . report excision recurrent HCC prove compare non-surgical treatment , subject recurrent HCC excision get high survival rate . However , excision rate recurrent HCC always arguable point . Nakajima et al . suggest excision rate 133 subject 24 % , Matsuda et al . agree 91 subject reach 44 % , Zhoo report 384 subject 35 % ; Kakazu et al . insist 286 subject 17 % ; Nagasue et al . say 290 subject 30 % ; Shoto et al . report 341 subject 19 % Poon et al . advocate 244 subject 10 % . He Sheng summarize 1295 subject recent five year , 106 opportunity excision ( 8.18 % ) . Sugimachi , Minagawa et al . report separately 5 year survival rate recurrent HCC subject 47.5 % 56.0 % , show significant difference first surgery , well therapeutic effect , meanwhile , third forth surgery could also get similar survival rate , indicate surgical excision vital treatment recurrent HCCs . Chen Han hospital report first , third , fifth , tenth year survival rate 162 recurrent HCC subject underwent first surgical treatment separately 96.8 % , 66.7 % , 43.6 % 21.8 % ; subject receive second surgical treatment separately 94.7 % , 44.9 % 25.0 % first , third , fifth year ( mean survival time 45 month , average survival time 54 month ) . In study , intend divide subject confirm recurrent HCC two group : Group A : treatment pure surgery Group B : treatment pure radio frequency . We compare non-tumor survival time , long-term survival rate two group , summarize merit demerit group , try establish standardized therapy treatment kind patient prospective study molecular biological difference pathological sample first second surgery .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . 20~60 year old ; 2. diagnose HCC pathologically , confirm recurrent HCC ultrasonic B , CT , MRI DSA test ; 3. good condition vital organ heart , lung , kidney ; 4. good liver function : Child A level , nearly A level hepatoprotection treatment ; 5. solitary small cancer focus ( diameter &lt; 5cm ) , number recurrent HCC focus three grow lobe liver ; 6. without jaundice ( include jaundice bile duct ) , without ascites extensive metastasis outside liver ; 7. without invasion portal vein . 1. subject refuse participate study ; 2. subject follow regularly ; 3. subject severe heart , lung , kidney disease ; 4. subject liver CP level B C , serum creatinine ≥2×ULN ; 5. subject severe bone marrow depression , neutrophil count low 1.5 × 109 .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>surgery</keyword>
</DOC>